Skip to main content

Cooperative Clinical Trials

  • Chapter
  • First Online:
Clinical Trials

Part of the book series: Success in Academic Surgery ((SIAS))

  • 1899 Accesses

Abstract

Cooperative clinical trials play a major role in advancing knowledge in the fields of medicine and surgery. The National Cancer Institute provides a robust infrastructure to help carry out these important studies for cancer, although multicenter trials certainly can be conducted outside of this mechanism with enough planning and coordination. In addition to the inherent value of the education and contribution to the scientific field, involvement in cooperative group research affords the opportunities for networking and mentorship, leadership training and career development, scientific discovery and funding, all of which can add to personal career satisfaction.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Juni P, Altman D, Egger M. Assessing the quality of randomised controlled trials. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Publishing Group; 2001.

    Google Scholar 

  2. Levin WC, et al. Cooperative clinical investigation. A modality of medical science. JAMA. 1974;227(11):1295–6.

    Article  CAS  Google Scholar 

  3. Klimt CR. Principles of multi-center clinical studies. In: Boissel JP, Klimt CR, editors. Multi-center controlled trials. principles and problems. Paris: INSERM; 1979.

    Google Scholar 

  4. https://www.cancer.gov/research/key-initiatives/immunotherapy.

  5. Coronary Drug Project Research Group. The Coronary Drug Project: methods and lessons of a multicenter clinical trial. Control Clin Trials. 1983;4(4):1–541.

    Google Scholar 

  6. Meinert CL. Clinical trials. Design, conduct and analysis. New York, NY: Oxford University Press; 1986.

    Book  Google Scholar 

  7. Corless CL, et al. Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial. J Clin Oncol. 2014;32(15):1563–70.

    Article  CAS  Google Scholar 

  8. Giuliano AE, et al. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318(10):918–26.

    Article  Google Scholar 

  9. Jang HJ, et al. The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials. Oncotarget. 2017;8(42):73009–16.

    Article  Google Scholar 

  10. Sandler A, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med. 2006;355(24):2542–50.

    Article  CAS  Google Scholar 

  11. Early Breast Cancer Trialists' Collaborative Group, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012;379(9814):432–44.

    Article  Google Scholar 

  12. http://iom.edu/Reports/2010/A-National-Cancer-Clinical-Trials-System-for-the-21st-Century-Reinvigorating-the-NCI-Cooperative.aspx.

  13. Institute of Medicine. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. Washington, DC: The National Academies Press; 2010. https://doi.org/10.17226/12879.

    Book  Google Scholar 

  14. https://www.ascopost.com/issues/march-15-2014/the-evolution-of-us-cooperative-group-trials-publicly-funded-cancer-research-at-a-crossroads/.

  15. Patlak M, et al. Multi-center phase III clinical trials and NCI cooperative groups: workshop summary, vol. xii. Washington, DC: National Academies Press; 2009. p. 121.

    Book  Google Scholar 

  16. https://dctd.cancer.gov/MajorInitiatives/NCI-sponsored_trials_in_precision_medicine.htm.

  17. https://www.allianceforclinicaltrialsinoncology.org/main/.

  18. https://ecog-acrin.org/.

  19. https://www.nrgoncology.org/.

  20. https://www.swog.org/.

  21. https://childrensoncologygroup.org/.

  22. https://www.ctg.queensu.ca/.

  23. https://www.cancer.gov/research/nci-role/cancer-centers.

  24. https://www.cancer.gov/research/areas/clinical-trials/nctn.

  25. https://www.cancer.gov/research/areas/clinical-trials/ncorp.

  26. https://www.cancer.gov/about-nci/organization/ccct/steering-committees/nctn.

  27. https://www.cancer.gov/about-nci/organization/ccct.

  28. https://deainfo.nci.nih.gov/advisory/ctac/ctac.htm.

  29. American College of Surgeons Clinical Research Program, Alliance for Clinical Trials in Oncology, Nelson HD, Hunt KK. Operative standards for cancer surgery, volume i: breast, lung, pancreas, colon. Philadelphia, PA: Wolters Kluwer Health; 2015.

    Google Scholar 

  30. American College of Surgeons Clinical Research Program, Alliance for Clinical Trials in Oncology, Katz MHG. Operative standards for cancer surgery, volume ii: thyroid, gastric, rectum, esophagus, melanoma. Philadelphia, PA: Wolters Kluwer Health; 2018.

    Google Scholar 

  31. https://ctep.cancer.gov/protocolDevelopment/letter_of_intent.htm.

  32. Friedman L, DeMets D. The data monitoring committee: how it operates and why. IRB. 1981;3:6–8.

    Article  Google Scholar 

  33. Fleming TR, DeMets DL. Monitoring of clinical trials: issues and recommendations. Control Clin Trials. 1993;14(3):183–97.

    Article  CAS  Google Scholar 

  34. Angell M, Kassirer JP. Setting the research straight in the breast-cancer trials. N Engl J Med. 1994;330:1448–50.

    Article  CAS  Google Scholar 

  35. Cohen J. Clinical trial monitoring: hit or miss? Science. 1994;264(5165):1534–7.

    Article  CAS  Google Scholar 

  36. Uy GL, Katz MHG, Boughey JC. Junior investigators: get engaged in the Alliance for Clinical Trials in Oncology. Bull Am Coll Surg. 2017;102(4):62–3.

    PubMed  PubMed Central  Google Scholar 

  37. Eisenstein EL, et al. Sensible approaches for reducing clinical trial costs. Clin Trials. 2008;5(1):75–84.

    Article  Google Scholar 

  38. Chung KC, Song JW, W.S. Group. A guide to organizing a multicenter clinical trial. Plast Reconstr Surg. 2010;126(2):515–23.

    Article  CAS  Google Scholar 

  39. Krueger RA, Casey MA. Focus groups: a practical guide for applied research. Thousand Oaks, CA: Sage Publications; 2006.

    Google Scholar 

  40. Van de Ven AH, Delbecq AL. The nominal group as a research instrument for exploratory health studies. Am J Public Health. 1972;62:337–42.

    Article  Google Scholar 

  41. Dalkey NC. The Delphi method: an experimental study of group opinion. Santa Monica, CA: RAND Corp; 1969.

    Google Scholar 

  42. Katz MH, et al. Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial. Ann Surg Oncol. 2011;18(2):337–44.

    Article  Google Scholar 

  43. Phillips RK, et al. Local recurrence following ‘curative’ surgery for large bowel cancer: I. The overall picture. Br J Surg. 1984;71(1):12–6.

    Article  CAS  Google Scholar 

  44. Stocchi L, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol. 2001;19(18):3895–902.

    Article  CAS  Google Scholar 

  45. Holm T, et al. Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg. 1997;84(5):657–63.

    Article  CAS  Google Scholar 

  46. Kockerling F, et al. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol. 1998;16(1):324–9.

    Article  CAS  Google Scholar 

  47. Nelson H, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93(8):583–96.

    Article  CAS  Google Scholar 

  48. American Joint Committee on Cancer. Exocrine pancreas. In: Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. Chicago, IL: Springer; 2002. p. 157–64.

    Chapter  Google Scholar 

  49. College of American Pathologists. Cancer protocols [16 August 2010]; Pancreas (exocrine); 2009. http://www.cap.org/apps/docs/committees/cancer/cancer_protocols/2009/PancreasExo_09protocol.pdf.

  50. American Joint Committee on Cancer. Exocrine pancreas. In: Edge SB, Byrd DR, Compton CC, et al., editors. AJCC cancer staging manual. 7th ed. Chicago, IL: Springer; 2009. p. 241–9.

    Google Scholar 

  51. Menon KV, et al. Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford). 2009;11(1):18–24.

    Article  Google Scholar 

  52. Staley CA, et al. The need for standardized pathologic staging of pancreaticoduodenectomy specimens. Pancreas. 1996;12(4):373–80.

    Article  CAS  Google Scholar 

  53. Chatelain D, Flejou JF. Pancreatectomy for adenocarcinoma: prognostic factors, recommendations for pathological reports. Ann Pathol. 2002;22(5):422–31.

    PubMed  Google Scholar 

  54. Luttges J, Zamboni G, Kloppel G. Recommendation for the examination of pancreaticoduodenectomy specimens removed from patients with carcinoma of the exocrine pancreas. A proposal for a standardized pathological staging of pancreaticoduodenectomy specimens including a checklist. Dig Surg. 1999;16(4):291–6.

    Article  CAS  Google Scholar 

  55. Khalifa MA, Maksymov V, Rowsell C. Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist. Virchows Arch. 2009;454(2):125–31.

    Article  Google Scholar 

  56. Verbeke CS, et al. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93(10):1232–7.

    Article  CAS  Google Scholar 

  57. Nagtegaal ID, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20(7):1729–34.

    Article  Google Scholar 

  58. Stevenson AR, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314(13):1356–63.

    Article  CAS  Google Scholar 

  59. https://www.rcpa.edu.au/Library/Practising-Pathology/Structured-Pathology-Reporting-of-Cancer/Cancer-Protocols.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Matthew H. G. Katz .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Allen, C.J., Perri, G., Katz, M.H.G. (2020). Cooperative Clinical Trials. In: Pawlik, T., Sosa, J. (eds) Clinical Trials. Success in Academic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-030-35488-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-35488-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-35487-9

  • Online ISBN: 978-3-030-35488-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics